Author

Madeline King

University of California, Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Jennifer Lynne WhistleriD· 2 shared Anirudh GauriD· 1 shared Bethany P. CummingsiD· 1 shared Caroline M. Keeshen· 1 shared Christina K. KimiD· 1 shared Elinor Lewis· 1 shared Jessie MuiriD· 1 shared Julianna Glienke· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Jennifer Lynne WhistlerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

D3 dopamine receptors implicate a striatal neuronal subtype in the aversive effects of the antipsychotic drug quetiapine

Elinor Lewis, Jessie Muir, Ying C. Li, Madeline King, Kaden P. Adams, Julianna Glienke, Sarah Warren Gooding, Kevin J. Bender, Christina K. Kim, Jennifer Lynne Whistler

This study identifies D3R-expressing neurons in the NAc as mediators of quetiapine's aversive effects, showing that chronic treatment reduces this aversion.

bioRxiv · Apr 15, 2025 · PreprintNeuroscience

G protein-Coupled Receptor Associated Sorting ProteinGASP1 mediated trafficking of the Glucagon Like Peptide-1Receptor contributes to the development of tolerance toincretin drugs

Anirudh Gaur, Caroline M. Keeshen, Madeline King, Noah Dirks, Marcus F. Flisher, Bethany P. Cummings, Mark O. Huising, Jennifer L. Whistler

This study shows that GASP1-mediated GLP-1R trafficking contributes to tolerance to incretin drugs, suggesting a strategy to prevent tolerance by biasing drug engagement toward G protein signaling.

bioRxiv · Aug 9, 2024 · PreprintCell Biology